Nu Skin Enterprises, Inc. (NUS) is a Household & Personal Products company in the Consumer Defensive sector, currently trading at $7.74. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of NUS = $19.32 (+149.6% from the current price, the stock appears undervalued). Analyst consensus target is NUS = $11 (+42.1% upside).
Valuation: NUS trades at a trailing Price-to-Earnings (P/E) of 2.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.07.
Financials: revenue is $1.5B, -12.6%/yr average growth. Net income is $160M, growing at -562.7%/yr. Net profit margin is 10.8% (healthy). Gross margin is 69.4% (-2.3 pp trend).
Balance sheet: total debt is $364M against $805M equity (Debt-to-Equity (D/E) ratio 0.45, conservative). Current ratio is 2.08 (strong liquidity). Debt-to-assets is 25.9%. Total assets: $1.4B.
Analyst outlook: 0 / 11 analysts rate NUS as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 98/100 (Pass), Growth 15/100 (Fail), Past 75/100 (Partial), Health 83/100 (Pass), Moat 53/100 (Partial), Future 52/100 (Partial), Income 55/100 (Partial).
